IPH — Innate Pharma SA Share News
0.000.00%
Last trade - 00:00- €121.51m
- €130.82m
- €2.79m
Brief: Innate Pharma To Present ANKET Pre-Clinical Data With Partner Sanofi
Innate Pharma hits record high after positive data on cancer therapy
NASDAQ RESUMED AT 09:54 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:50 AM
NASDAQ RESUMED AT 09:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
Brief: Innate Pharma Flags Positive Data From AstaZeneca's Monalizumab Study
Innate Pharma rises ahead of cancer antibody data presentation
U.S. RESEARCH ROUNDUP- Alphabet, Facebook, Goldman Sachs
Brief: Innate Pharma H1 Operating Loss Widens To EUR 25.4 Mln
NASDAQ RESUMED AT 02:28 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:23 PM
NASDAQ RESUMED AT 01:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:47 PM
SVB Leerink bullish on lung cancer opportunity for Innate Pharma
Innate Pharma falls as its COVID-19 pneumonia drug fails
Brief: Innate Pharma To Stop Exploring Avdoralimab in Covid-19
Brief: Innate Pharma Presents Preliminary Data From Tellomak Trial Showing Clinical Response For Lacutamab In Mycosis Fungoides
Brief: Innate Pharma: positive set of first data from TELLOMAK